跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E
Authorized
STANDARD
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E
shiseido americas corporation dist
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d7851f2a8ba62010
Company
shiseido americas corporation dist
Type
Standard
Approval Details
Approval Id
d7851f2a8ba62010
Drug Approval Canada Name
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E
Product Name
FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E
Status
Marketed
Status Date
2017-09-08
Original Market Date
2017-09-08
Din
02461943
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0439065016
Company Name
shiseido americas corporation dist
Company Address
900 Third Avenue, New York, New York, United States, 10017
Active Ingredients
AVOBENZONE
2 %
OCTINOXATE
7.4 %
OCTOCRYLENE
3 %
OXYBENZONE
1.5 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d7851f2a8ba62010
Type
Standard
Back to Health Canada Approvals
